Allergy & Asthma Network educates thousands each year on appropriate medication use through programs like Anaphylaxis Community Experts and AAP Chapter Champions in Asthma, Allergy & Anaphylaxis. Support from partners like AAP, ACAAI, TEVA Respiratory, MEDA & Mylan Specialty LP are critical to ensure healthcare professionals and patients alike understand and use medications appropriately! Read the rest of this entry »
Medication mistakes involving young children occur all too frequently, and health care officials believe greater education is needed to ensure caregivers administer proper doses and consult a doctor if necessary.
This will be even more important if the U.S. Food and Drug Administration (FDA) approves more allergy and asthma medications for over-the-counter (OTC) status. Read the rest of this entry »
When natural disasters happen, you may have only precious minutes to grab what you need for a few days, weeks, or longer. Read the rest of this entry »
Allergy immunotherapy gradually builds a person’s tolerance to specific allergens by exposing the patient to ever-increasing doses over a period of time – eventually reducing or eliminating symptoms. Read the rest of this entry »
Allergy and asthma medications are at the forefront of the U.S. Food and Drug Administration (FDA) agenda this year as the agency considers moving more drugs from prescription to over-the-counter (OTC) status.
Two medications recently considered were Nasacort®, the corticosteroid nasal spray approved for OTC use in late 2013, and Primatene HFA, an OTC asthma bronchodilator still under consideration at this time.
You don’t want to take a chance, so you call 911 or go directly to the local hospital emergency room (ER).
What then? Read the rest of this entry »
VIENNA, VA, FEB. 19, 2014 – An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit patient education and advocacy organization.
On Feb. 25, FDA’s Nonprescription Drugs Advisory Committee and Read the rest of this entry »
In April 2013, the Food and Drug Administration (FDA) issued draft guidance that could allow new generic quick-relief albuterol inhalers onto pharmacy shelves without dose counters, leaving asthma patients playing a dangerous guessing game.
Read the rest of this entry »
McLEAN, VA, NOV. 13, 2013 – Allergy & Asthma Network Mothers of Asthmatics (AANMA) today commended President Obama for signing into law the School Access to Emergency Epinephrine Act, legislation that helps protect schoolchildren who experience anaphylaxis, a life-threatening allergic reaction.
On July 31, AANMA released results of our recent survey regarding patient use of intranasal corticosteroid sprays. Findings were shared during the Food and Drug Administration (FDA) Nonprescription Drug Advisory Committee meeting considering the switch of triamcinolone nasal spray from prescription to over-the-counter status.